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A tail fragment of Dictyostelium discoideum myosin has been cloned and expressed as a fusion protein with the N-terminal 
region of MS-2 polymerase. The cloned fragment was phosphorylated with myosin heavy chain kinase II from aggre- 
gation-competent D.discoideum cells that specifically phosphorylate threonine residues on the myosin tail. Phospho- 
peptide maps showed the same site specificity of phosphorylation with the fusion protein as a substrate as with native 
myosin. An improved assay for the kinase was developed in which the fusion protein is precipitated with a monoclonal 
antibody that inhibits polymerization of the myosin tails without preventing their phosphorylation. Sites of phosphoryla- 
tion were tentatively localized to a sequence in the C-terminal region of the heavy chain where four threonine residues 
are found. 
Myosin phosphorylation; Protein kinase; Cell motility; Cloned myosin tail fragment; (Dictyostelium discoideum) 
1. INTRODUCTION 
Phosphorylation of the MHC in Dicfyostelium 
discoideum is regulated by the chemoattractant 
cyclic AMP [l-4]. A MHC kinase, designated as 
MHC kinase II, was partially purified from 
aggregation-competent cells and found to be inac- 
tivated by Ca2+ and calmodulin [5]. This result 
suggested that the kinase is involved in signal 
transmission, although the mechanism of this inac- 
tivation remained unknown. Phosphopeptide 
mapping showed that two or more threonine 
residues are phosphorylated by MHC kinase II [5]. 
A myosin kinase purified from growth-phase cells 
also specifically phosphorylated threonine residues 
on the heavy chain [6]. The activity of this kinase 
was not significantly altered by Ca2+ and 
calmodulin, and its relationship to MHC kinase II 
is unclear. Direct comparison of the kinases and 
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their regulatory properties depends on the 
availability of a more specific substrate than intact 
myosin, since in the latter serine residues on the 
light chains and both serine and threonine residues 
on the heavy chains are phosphorylated [3,4]. We 
have subcloned the MHC for the use of fusion pro- 
teins as better defined substrates for kinases, in 
order to specify phosphorylation sites and to 
eliminate two difficulties in quantitating MHC 
kinase activities. One difficulty is the consumption 
of ATP by the myosin ATPase activity, another 
the polymerization of myosin under the low-salt 
conditions under which the kinases are active [5,6]. 
2. MATERIALS AND METHODS 
2.1. MHC specific DNA clones 
A hgt 11 expression library containing EcoRI cut genomic 
DNA from D. discoideum strain AX2 [7] was screened with 
‘*‘I-labeled mAb 253. Phage hgm159 expressed a protein 
recognized by the antibody and contained a 1.5 kb insert. The 
sequence of both strands of the insert was determined using the 
dideoxynucleotide chain termination method [S] after subclon- 
ing into M13mp18 or mp19 and pUC19 [9]. 
Since the fusion protein produced in Xgtll proved to be in- 
stable, the insert of hgm159 was cloned into the EcoRI site of 
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plasmid pEx33B (Schaller, H., personal communication) and 
expressed in E. co/i C600 [lo]. The plasmid contains the hPL 
promoter followed by the coding sequence for the N-terminal 
99 amino acids of phage MS-2 polymerase and a synthetic 
polylinker. The plasmid containing the insert of hgm159 was 
designated aspm159. Xholl fragments of the insert were cloned 
into the EcoRl and BumHI sites of pEx33A or B. A subclone 
containing the 0.9 kb fragment in pEx33B was designated as 
pmI2, and a subclone containing the 0.6 kb fragment in 
pEx33A as pm4. 
2.2. Purification of proteins 
For expression of fusion proteins, transformed E. coli cells 
were cultivated overnight at 28°C in LB medium containing 
5Opg per ml each of ampicillin and kanamycin, then diluted 
5-fold into prewarmed LB medium and incubated for 2 h at 
42°C. Bacteria from a 200-ml culture were washed twice in cold 
30 mM Tris-HCl buffer, pH 7.5. For partial purification of the 
proteins, a procedure described for the c-myc protooncogene 
[ll] was modified. Lysozyme-, DNase- and RNase-treated 
bacteria were lysed by sonication on ice, and the 10000 x g 
pellet was extracted with 20 ml TEDGA buffer (20 mM Tris- 
HCl buffer, pH 7.5; 1 mM EGTA; 1 mM DTT; 5% glycerol; 
0.02% NaN,) supplemented with 10 mM benzamidine, 0.5 mM 
PMSF and 10 mM Chaps (Calbiochem). The pellet was ex- 
tracted on ice with 20 ml TEDGA buffer and 5 M urea (Biorad, 
deionized with Amberlite). The extract was centrifuged as 
above and the supernatant loaded onto a 20 ml DE-52 column 
(Whatman) equilibrated with TEDGA buffer and 5 M urea. In 
a linear gradient of NaCl in TEDGA buffer and 5 M urea the 
fusion protein eluted between 50 mM and 100 mM NaCl. The 
partially purified fusion protein was dialysed against 20 mM 
TDSA buffer (Tris-HCl, pH 7.5; 15% sucrose; 1 mM DTT; 
0.02% NaN3) and, after removal of debris, stored with 50% 
glycerol at -20°C. 
D. discoideum myosin was purified from aggregation- 
competent AX2 cells as described [5]. MHC kinase II was par- 
tially purified from aggregation-competent AX2 cells essentially 
by procedure II of Maruta et al. [5], omitting the final Blue 
Sepharose and Sephadex G-100 steps. 
2.3. Immunoblotting, precipitation and phosphorylation 
IgG of mAb 96 or mAb 253 (121 was purified from 
hybridoma culture supernatants. For immunoblotting of fusion 
proteins, bacteria were lysed in SDS-sample buffer, and pro- 
teins separated in 7.5% or 10% SDS-polyacrylamide gels were 
transferred to BA85 nitrocellulose filters (Schleicher and 
Schiill). The blots were labeled with mAb 253 or mAb 96 that 
were iodinated using the chloramine T method. 
For immunoprecipitation, 40pg IgG in TDSA buffer and 
100 pg of partially purified fusion protein or 20 pg of purified 
myosin were incubated overnight at 4OC in TDSA containing 
150 mM NaCl. After the addition of 40~1 swollen protein A- 
Sepharose beads (Pharmacia) in 160 pl TDSA-NaCl, incubation 
at 4°C was continued with gentle shaking for 30 min. The beads 
were pelleted by short centrifugation and washed twice with 
500~1 TDSA in the cold. For phosphorylation with partially 
purified MHC kinase II, the beads were suspended in TDSA 
supplemented with 1 mM EGTA, 5 mM MgClz and 10 PM “P- 
ATP (10’ cpm per nmol). After 30 min of incubation at 35”C, 
the beads were washed twice with TDSA, boiled in SDS-sample 
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buffer and subjected to SDS-polyacrylamide gel elec- 
trophoresis. 
2.4. Phosphopeptide mapping and identification of 
phosphothreonine 
The 74 kDa fusion protein or purified D. discoideum myosin 
was precipitated using mAb 96 and 32P-phosphorylated with 
MHC kinase II. After SDS-polyacrylamide gel electrophoresis, 
bands of proteins were cut from the dried gel and extracted 
under digestion for 30 h at 35°C with 5 pg of trypsin and 5 pg 
of chymotrypsin in 0.5 ml of 10 mM NHdHCO3 (pH 8.0) [13]. 
Peptides were separated by thin-layer electrophoresis and 
chromatography on cellulose sheets [5]. For identification of 
phosphoamino acids, the extract was hydrolysed for 2 h at 
110°C with 6 M HCl under vacuum. After addition of unla- 
beled authentic phosphoamino acids the mixture was separated 
by two-dimensional electrophoresis [14], autoradiographed and 
stained with ninhydrin. 
3. RESULTS 
3.1. Characterization and partial purification of 
cloned myosin heavy-chain fragments 
The sequence of a genomic EcoRI fragment 
proved to be identical with that of nucleotides 4598 
to 6097 of the complete MHC sequence which con- 
sists of one continuous exon [15]. The 1.5 kb frag- 
ment encodes amino acids 1534 to 2032 of the 
MHC, lacking at its 3’-end the coding region for 
the 84 C-terminal amino acids. The fusion protein 
that contained 11 kDa of MS-2 polymerase in ad- 
dition to the 58 kDa of the MHC fragment showed 
an apparent molecular mass of 74 kDa in 7.5% 
SDS-polyacrylamide gels. It was labeled with mAb 
253 and mAb 96. The latter antibody binds close to 
the threonine residues phosphorylated by MHC 
kinase II [16]. 
Subcloning of the 1.5 kb EcoRI fragment gave 
rise to a 0.9 kb 5 ’ -fragment that was expressed as 
a 46 kDa fusion protein, and to a 0.6 kb 
3 ’ -fragment that yielded a 32 kDa fusion protein. 
The 46 kDa protein bound only mAb 253, the 
32 kDa protein only mAb 96. 
3.2. Phosphorylation of fusion proteins 
The partially purified 74 kDa fusion protein was 
incubated with mAb 96 or mAb 253 and 
precipitated with protein A-Sepharose. Both an- 
tibodies prevent the polymerization of myosin 
[ 121. Phosphorylation of the immunoprecipitates 
drastically reduced background due to 
phosphorylation of other proteins in the partially 
purified preparations. After incubation of the im- 
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Fig.1. Phosphorylation of the 74 kDa fusion protein after 
immunoprecipitation (A), and identification of threonine as the 
phosphorylated amino acid (B). (A) The partially purified 
fusion protein was immunoprecipitated with mAb 96 (lane 1) or 
mAb 253 (lane 2), phosphorylated with MHC kinase II and 
[y-32P]ATP, and subjected to SDS-polyacrylamide gel 
electrophoresis and autoradiography. Positions of molecular 
mass markers are indicated on the left. After incubation of 
either the kinase preparation or the substrate alone with 
[y-32P]ATP, no labeled band was seen (not shown). (B) The 
74 kDa fusion protein was hydrolysed and phosphoamino acids 
were separated. Positions of authentic phosphoamino acids are 
indicated on the autoradiogram by dotted lines. 
munoprecipitates with [y-32P]ATP and MHC 
kinase II, the 32P label was primarily found in the 
74 kDa band of the fusion protein (fig. 1A). Minor 
phosphorylated polypeptides were most likely 
degradation products of the 74 kDa protein. These 
existed already in the bacteria and were copurified 
with the fusion protein. 
Only phosphothreonine residues of the fusion 
protein were labeled with MHC kinase II (fig.lB), 
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Fig.2. Two-dimensional phosphopeptide patterns obtained 
from intact myosin heavy chains (A), the 74 kDa fusion protein 
(B), or a mixture of both (C). After incubation of myosin with 
MHC kinase II and [Y-~~P]ATP, the heavy chains were digested 
with trypsin and chymotrypsin. The direction of electrophoresis 
of the phosphopeptides was from left (+) to right (-). The 
direction of chromatography was from bottom to top. 
as was the case with normal myosin [S]. 
Phosphopeptide mapping of myosin and fusion 
protein resulted in superimposable phosphopep- 
tide patterns (fig.2). Thus all threonine residues 
phosphorylated by MHC kinase II appear to be 
located in the cloned 58 kDa fragment of the 
myosin tail. 
4. DISCUSSION 
The results reported here are combined in fig.3 
with previous data [12,16,17] indicating that the 
threonine residues phosphorylated by MHC kinase 
II are located in a 38 kDa fragment from the MHC 
73 
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Fig.3. Map of the D. discoideum myosin heavy chain and of the cloned fragments (A) and sequence of a portion of the MHC that 
contains putative phosphorylation sites (B). This sequence has been derived from the DNA sequence of the insert of Xgml59 that codes 
for the 58 kDa polypeptide shown in A. (A) EcoRI and X/z011 sites used for cloning and subcloning are indicated on top, and 
boundaries of the encoded polypeptides below. The hatched area indicates a region containing phosphorylation sites, as predicted from 
the apparent molecular masses of partial chymotryptic fragments of myosin phosphorylated with MHC kinase II [16]. The two lines 
on bottom indicate the positions of mAb binding sites on the myosin tail as revealed by electron microscopy [12,17]. All antibodies 
were tested for binding to the cloned fragments. Only mAbs 253 and 96 bound to the 58 kDa fragment; mAb 253 to the 33 kDa 
subfragment and mAb 96 to the 25 kDa one. (B) Amino acid residues are numbered according to the complete coding sequence of 
the MHC gene [15]. Threonine residues are boxed, the approximate extension of the region hatched in A is underlined. The position 
of the XhoII site used for subcloning of the DNA is indicated. 
C-terminal region. This fragment was recognized 
by mAb 96 and 55, but not by mAb 253. A smaller 
C-terminal fragment of 32 kDa lacked both the 
mAb 96 binding site and the phosphorylated 
threonine residues. These data suggested that the 
phosphorylated sites are located within the hatched 
area of fig.3A. This region is underlined in the se- 
quence of the 58 kDa fragment shown in fig.3B. 
Among the 24 threonine residues encompassed by 
the cloned fragment, residues 1823, 1833, 1835 and 
1837 are located in that ‘region, and four others in 
the flanking sequences up to a distance of 30 
amino acids on both sides. In the central group of 
four residues, which are the most likely sites 
phosphorylated by MHC kinase II, a single 
threonine residue is separated from a cluster of 
three by an amino acid stretch that contains 
cleavage sites for trypsin and chymotrypsin. This 
74 
fits to the phosphopeptide pattern which indicates 
at least two phosphorylatable threonine residues 
which are separated by cleavage sites for both these 
enzymes [ 51. 
The results presented show that intact D. 
discoideum myosin can be replaced as a substrate 
for MHC kinase II by a fusion protein containing 
an internal MHC fragment which represents about 
20% of the total size of the heavy chain. The fu- 
sion protein is easier to prepare and is a better stan- 
dardized substrate for the kinase than myosin 
which might retain phosphate when it is purified 
from D. discoideum cells [5,6]. Use of the fusion 
protein will facilitate distinction of MHC kinase II 
from myosin kinases that phosphorylate other 
residues on heavy or light chains, and thus will 
help to elucidate the mechanisms by which these 
kinases are regulated. 
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